Allianz Asset Management
MRNA icon

Allianz Asset Management’s Moderna MRNA Stock Holding History

Allianz Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,900
Closed -$82.2K – 2196
2025
Q1 		$82.2K Hold
2,900
– – ﹤0.01% 2181
2024
Q4 		$121K Hold
2,900
– – ﹤0.01% 2136
2024
Q3 		$194K Sell
2,900
-3,200
-52% -$294K ﹤0.01% 2089
2024
Q2 		$724K Buy
+6,100
New +$772K ﹤0.01% 1710
2024
Q1 		– Sell
-100
Closed -$9.95K – 2190
2023
Q4 		$9.95K Sell
100
-3,600
-97% -$303K ﹤0.01% 2113
2023
Q3 		$382K Sell
3,700
-5,200
-58% -$580K ﹤0.01% 2012
2023
Q2 		$1.08M Sell
8,900
-800
-8% -$107K ﹤0.01% 1499
2023
Q1 		$1.49M Buy
9,700
+900
+10% +$148K ﹤0.01% 1500
2022
Q4 		$1.58M Buy
8,800
+8,100
+1,157% +$1.32M ﹤0.01% 1361
2022
Q3 		$83K Sell
700
-1,400
-67% -$212K ﹤0.01% 1691
2022
Q2 		$300K Sell
2,100
-5,200
-71% -$743K ﹤0.01% 2014
2022
Q1 		$1.26M Buy
7,300
+5,700
+356% +$960K ﹤0.01% 1763
2021
Q4 		$406K Sell
1,600
-7,500
-82% -$2.19M ﹤0.01% 2283
2021
Q3 		$3.5M Buy
+9,100
New +$3.36M ﹤0.01% 1429
2020
Q4 		– Sell
-13,700
Closed -$969K – 1919
2020
Q3 		$969K Buy
+13,700
New +$955K ﹤0.01% 1439

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allianz Asset Management's MRNA Position: Q1 2026 in Review

Allianz Asset Management increased its Moderna (MRNA) stake by 5,455% in Q1 2026, buying an estimated $45.3M and bringing the position to 988,908 shares worth $50.2M. The position accounts for 0.05% of the portfolio, ranked #327.

Allianz Asset Management first reported a position in MRNA in Q3 2019 and has held it in 25 quarters since. The position peaked at $464M in Q2 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Allianz Asset Management held 988,908 shares of Moderna worth $50.2M as of Q1 2026.
  • Allianz Asset Management bought 971,107 Moderna shares in Q1 2026, an estimated $45.3M.
  • Moderna made up 0.05% of Allianz Asset Management's portfolio in Q1 2026, its #327 holding.
  • Allianz Asset Management first reported a position in Moderna in Q3 2019 and has held it in 25 quarters since.
  • Allianz Asset Management's Moderna position peaked at $464M in Q2 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.